NCT06459115Completed
Adherence to Medication in Patients With Acute Decompensated Heart Failure
Adherence to Medication in Patients With Acute Decompensated Heart Failure: a Cross-sectional Study at the Emergency Department (ADHF-ED= Adherence to Medication in Patients With Acute Decompensated Heart Failure at the Emergency Department)
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
Every day, patients present to emergency department due to acute heart failure. There are many causes for decompensation. One possible cause is a lack of adherence to heart failure medication (prognosis-improving medications and diuretics). The aim of this study is to directly measure adherence in patients with acute heart failure (gold standard of adherence measurement using liquid chromatography coupled to high-resolution mass spectrometry= LC-HRMS/MS) at the emergency department. Questionnaires are used to investigate possible factors influencing adherence.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 10 Jun 2024
- Start date
- 1 Feb 2023
- Primary completion date
- 1 May 2024
- Lead sponsor
- Universität des Saarlandes
- Diseases
- Heart failure
- NCT number
- NCT06459115
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Feb 2023 to the primary completion date, 1 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Not able to give written informed consent
Who the study is looking for
- age ≥18 years of age
- known chronic heart failure irrespective of ejection fraction (heart failure with reduced, mildly reduced, or preserved ejection fraction)
- requirement of intravenous diuretics (outpatient or stationary treatment)
- stable heart failure medication \>2 weeks
- ≥1 sign of volume overload (peripheral edema, jugular venous distension, pulmonary rales, ascites, or demonstration of pulmonary venous congestion on chest X-ray)
- elevated natriuretic peptides (N-terminal pro brain natriuretic peptide= nt-pro-BNP ≥125 pg/ml)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Saarland, Saarland University Coordinator of this site? Confirm its status | Homburg | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.